✦ LIBER ✦

MP-4.12: Prevalence of Lower Urinary Tract Symptoms (LUTS) in Men with Adenocarcinoma of the Prostate, and Prospective Randomized Evaluation of the Alpha-adrenergic Blocker Doxazosin for the Treatment of LUTS in Men with Prostate Cancer

✍ Scribed by C. Heyns; J. Stander

Book ID: 116949831
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 61 KB
Volume: 72
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2008.08.254

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination Therapy with Rofecoxib and F

Combination Therapy with Rofecoxib and Finasteride in the Treatment of Men with Lower Urinary Tract Symptoms (LUTS) and Benign Prostatic Hyperplasia (BPH)

✍ Franco Di Silverio; Cesare Bosman; Monti Salvatori; Luca Albanesi; Laura Proiett 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Combination Therapy With Rofecoxib and F

Combination Therapy With Rofecoxib and Finasteride in the Treatment of Men With Lower Urinary Tract Symptoms (LUTS) and Benign Prostatic Hyperplasia (BPH)

✍ Di Silverio, F.; Bosman, C.; Salvatori, M.; Albanesi, L.; Proietti Pannunzi, L.; 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 44 KB

842Combination therapy with rofecoxib an

842Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS)

✍ A. Sciarra; A. Cardi; L. Albanesi; G. Salvatori; A. Salsiccia; A.M. Autran Gomez 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 197 KB

THE EFFICACY AND SAFETY OF TADALAFIL ADM

THE EFFICACY AND SAFETY OF TADALAFIL ADMINISTERED ONCE A DAY FOR LOWER URINARY TRACT SYMPTOMS (LUTS) IN MEN WITH BENIGN PROSTATIC HYPERPLASIA (BPH)

✍ K. Mc Vary; C. Roehrborn; J. Kaminetsky; S. Auerbach; B. Wachs; J. Young; A. Esl 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 67 KB

PD-02.08: The efficacy and safety of tad

PD-02.08: The efficacy and safety of tadalafil administered once a day for lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH)

✍ C.G. Roehrborn; K.T. McVary; J.D. Kaminestsky; S.M. Auerbach; B. Wachs; J.M. You 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 89 KB

MP-20.02: The efficacy, duration of effi

MP-20.02: The efficacy, duration of efficacy and safety of Ozarelix, a novel GnRH antagonist, in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH)

✍ B. Denes; A.V. Bantchev; S.S. Karanikolov; M. Nikolovski; P. Pantchev; L.D. Petk 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 86 KB